Hypercholesterolemia, Familial, 4, Autosomal Recessive
Showing 1 - 25 of >10,000
Hypercholesterolemia, Familial, Hypercholesterolemia, Familial, 1, Hypercholesterolemia, Familial, 2 Trial in Moscow (genetic,
Recruiting
- Hypercholesterolemia, Familial
- +25 more
- Genetic Testing
- +7 more
-
Moscow, Russian FederationNational Medical Research Centre for Therapy and Preventive Medi
Jul 25, 2022
People With Generalized Arterial Calcification of Infancy or
Completed
- Generalized Arterial Calcification of Infancy
- Autosomal Recessive Hypophosphatemic Rickets Type2
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Familial Hypercholesterolemia - Heterozygous Trial in Paris (CAC Score)
Completed
- Familial Hypercholesterolemia - Heterozygous
- CAC Score
-
Paris, FranceHôpital Pitié-Salpêtrière
Sep 9, 2021
Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol
Recruiting
- Adenine Phosphoribosyltransferase Deficiency
- +83 more
-
Bristol, South West, United KingdomZoe Plummer
Sep 26, 2023
Homozygous Familial Hypercholesterolemia Trial in Australia, Canada, United States (ARO-ANG 3 Injection)
Recruiting
- Homozygous Familial Hypercholesterolemia
- ARO-ANG 3 Injection
-
Mount Sinai, New York
- +7 more
Sep 26, 2022
Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial
Not yet recruiting
- Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency
- +2 more
- INZ-701
- Control Arm (Conventional Therapy)
- (no location specified)
Sep 18, 2023
Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial
Not yet recruiting
- Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
- +2 more
- (no location specified)
Feb 15, 2023
Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney
Recruiting
- Rare Disorders
- +309 more
-
Sioux Falls, South Dakota
- +1 more
Jun 20, 2022
Hypercholesterolemia Trial in Beijing (IBI306 450mg SC Q4W, Placebo SC Q4W, IBI306 600mg SC Q6W)
Completed
- Hypercholesterolemia
- IBI306 450mg SC Q4W
- +3 more
-
Beijing, ChinaPeking University First Hospital
Apr 2, 2022
Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial
Recruiting
- Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
- +2 more
-
Rochester, Minnesota
- +2 more
Jan 4, 2022
Familial Hypercholesterolemia, Lipid Disorder Trial in Montreal
Recruiting
- Familial Hypercholesterolemia
- Lipid Disorder
-
Montreal, Quebec, CanadaResearch Institute of the McGill University Health Centre: Glen
Oct 8, 2021
Severe Familial Hypercholesterolemia Trial in Worldwide (Evolocumab)
Completed
- Severe Familial Hypercholesterolemia
- Evolocumab
-
Los Angeles, California
- +43 more
Nov 3, 2022
Familial Hypercholesterolemia Trial in Worldwide (Evolocumab)
Completed
- Familial Hypercholesterolemia
- Evolocumab
-
Bronx, New York
- +45 more
Dec 16, 2021
Baby Detect : Genomic Newborn Screening
Recruiting
- Congenital Adrenal Hyperplasia
- +126 more
-
Liege, Wallonia, BelgiumCRMN, Hôpital La Citadelle
Jan 24, 2023
Pediatric Heterozygous Hypercholesterolemia Trial in Quebec, Athens, Oslo (Atorvastatin)
Completed
- Pediatric Heterozygous Hypercholesterolemia
-
Quebec, Canada
- +2 more
Feb 17, 2021
Homozygous Familial Hypercholesterolemia Trial in Worldwide (evinacumab)
Active, not recruiting
- Homozygous Familial Hypercholesterolemia
-
Los Angeles, California
- +37 more
Feb 17, 2022
Familial Hypercholesterolemia - Heterozygous Trial in Worldwide (Inclisiran, Placebo)
Recruiting
- Familial Hypercholesterolemia - Heterozygous
- Inclisiran
- Placebo
-
Tucson, Arizona
- +76 more
Aug 8, 2022
Homozygous Familial Hypercholesterolemia Trial in Worldwide (Alirocumab, Placebo)
Completed
- Homozygous Familial Hypercholesterolemia
- Alirocumab
- Placebo
-
Boca Raton, Florida
- +27 more
Jun 7, 2021
Spectrum of ENPP1 Deficiency and Acute ABCC6 Deficiency
Completed
- Generalized Arterial Calcification in Infancy
- Autosomal Recessive Hypophosphatemic Rickets Type 2
-
Eagan, MinnesotaEngage Health
Mar 30, 2021
Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH)
Active, not recruiting
- Lipoprotein Lipase Deficiency
- +2 more
-
Rostock, Germany
- +3 more
May 12, 2021
Autosomal Recessive Ichthyosis Trial in Rancho Santa Margarita (KB105, Placebo)
Not yet recruiting
- Autosomal Recessive Ichthyosis
- KB105
- Placebo
-
Rancho Santa Margarita, CaliforniaMission Dermatology
Feb 20, 2023
Hypercholesterolaemia Trial in Worldwide (Alirocumab SAR236553 (REGN727), Rosuvastatin, Atorvastatin)
Active, not recruiting
- Hypercholesterolaemia
- Alirocumab SAR236553 (REGN727)
- +12 more
-
Boca Raton, Florida
- +45 more
Jan 12, 2022
Homozygous Familial Hypercholesterolemia Trial in Worldwide (evinacumab, Placebo)
Completed
- Homozygous Familial Hypercholesterolemia
- evinacumab
- Placebo
-
Boca Raton, Florida
- +29 more
Apr 26, 2021
Stargardt Disease, Stargardt Macular Degeneration, Stargardt Macular Dystrophy Trial in Somerville (ALK-001)
Enrolling by invitation
- Stargardt Disease
- +3 more
-
Somerville, MassachusettsCoordinating Center
Jul 19, 2021